Literature DB >> 29355866

Optimum morphology of gold nanorods for light-induced hyperthermia.

Jordi Morales-Dalmau1, Clara Vilches, Ignacio de Miguel, Vanesa Sanz, Romain Quidant.   

Abstract

Owing to their unique chemical and physical properties, colloidal gold nanoparticles have prompted a wide variety of biocompatible nano-agents for cancer imaging, diagnosis and treatment. In this context, biofunctionalized gold nanorods (AuNRs) are promising candidates for light-induced hyperthermia, to cause local and selective damage in malignant tissue. Yet, the efficacy of AuNR-based hyperthermia is highly dependent on several experimental parameters; in particular, the AuNR morphology strongly affects both physical and biological processes. In the present work, we systematically study the influence of different structural parameters like the AuNR aspect ratio, length and molecular weight on in vitro cytotoxicity, cellular uptake and heat generation efficiency. Our results enable us to identify the optimum AuNR morphology to be used for in vivo hyperthermia treatment.

Entities:  

Year:  2018        PMID: 29355866     DOI: 10.1039/c7nr06825e

Source DB:  PubMed          Journal:  Nanoscale        ISSN: 2040-3364            Impact factor:   7.790


  3 in total

1.  Photoemission of Plasmonic Gold Nanostars in Laser-Controlled Electron Current Devices for Technical and Biomedical Applications.

Authors:  Alexander N Yakunin; Yury A Avetisyan; Garif G Akchurin; Sergey V Zarkov; Nikolay P Aban'shin; Vitaly A Khanadeev; Valery V Tuchin
Journal:  Sensors (Basel)       Date:  2022-05-29       Impact factor: 3.847

Review 2.  Thermo-Sensitive Nanomaterials: Recent Advance in Synthesis and Biomedical Applications.

Authors:  Paola Sánchez-Moreno; Juan de Vicente; Stefania Nardecchia; Juan A Marchal; Houria Boulaiz
Journal:  Nanomaterials (Basel)       Date:  2018-11-13       Impact factor: 5.719

Review 3.  Gold Nanorods for Drug and Gene Delivery: An Overview of Recent Advancements.

Authors:  Atieh Jahangiri-Manesh; Marziyeh Mousazadeh; Shirinsadat Taji; Abbas Bahmani; Atefeh Zarepour; Ali Zarrabi; Esmaeel Sharifi; Mostafa Azimzadeh
Journal:  Pharmaceutics       Date:  2022-03-17       Impact factor: 6.321

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.